Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade …
C Chu, S Zeng, AA Hasan, CF Hocher… - British Journal of …, 2021 - Wiley Online Library
Aims Angiotensin‐converting enzyme‐2 (ACE2) is the receptor for SARS‐CoV‐2. Animal
studies suggest that renin–angiotensin–aldosterone system (RAAS) blockers might increase …
studies suggest that renin–angiotensin–aldosterone system (RAAS) blockers might increase …
The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction
MV Genuardi, PJ Mather - Therapeutic Advances in …, 2021 - journals.sagepub.com
Sodium-glucose cotransporter type 2 (SGLT2) inhibitors are a relatively new class of
antihyperglycemic drug with salutary effects on glucose control, body weight, and blood …
antihyperglycemic drug with salutary effects on glucose control, body weight, and blood …
The Cardiology Society of India-Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy
S Joseph, J Panniyammakal… - European Heart …, 2022 - academic.oup.com
Aims Data on the burden of acute heart failure (AHF) admissions, practice patterns, and
outcomes are rare from India and other low-and middle-income countries. We aimed to …
outcomes are rare from India and other low-and middle-income countries. We aimed to …
[HTML][HTML] Insuficiencia cardíaca crónica en Argentina. OFFICE IC AR, un registro conjunto de la Sociedad Argentina de Cardiología y de la Federación Argentina de …
J Thierer, ER Perna, J Marino… - Revista argentina de …, 2022 - SciELO Argentina
Objetivos: Describir en forma amplia y comprensiva las características salientes de la ICC
en Argentina, incluyendo las características de los pacientes, el uso de recursos …
en Argentina, incluyendo las características de los pacientes, el uso de recursos …
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis
G Armentaro, V Condoleo, C Pelaia, V Cassano… - Internal and Emergency …, 2023 - Springer
Abstract Sacubitril/Valsartan (Sac-Val) has improved clinical prognosis in patients affected
by heart failure (HF) with reduced ejection fraction (HFrEF). Comorbidities have a crucial …
by heart failure (HF) with reduced ejection fraction (HFrEF). Comorbidities have a crucial …
[HTML][HTML] Estimated population prevalence of heart failure with reduced ejection fraction in Spain, according to DAPA-HF study criteria
A Camps-Vilaró, JF Delgado-Jiménez, N Farré… - Journal of clinical …, 2020 - mdpi.com
Heart failure (HF) is one of the main causes of morbidity, mortality, and high healthcare
costs. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced …
costs. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced …
[HTML][HTML] Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to …
M Jarjour, A Ducharme - Drugs in Context, 2023 - ncbi.nlm.nih.gov
Heart failure is a growing epidemic with high mortality rates and recurrent hospital
admissions that creates a burden on affected individuals, their caregivers and the whole …
admissions that creates a burden on affected individuals, their caregivers and the whole …
[HTML][HTML] A Simple score to identify super-responders to sacubitril/valsartan in ambulatory patients with heart failure
C Moliner-Abós, D Mojón Álvarez… - Frontiers in …, 2021 - frontiersin.org
Introduction Sacubitril/valsartan (SV) promotes cardiac remodeling and improves prognosis
in patients with heart failure (HF). However, the response to the drug may vary between …
in patients with heart failure (HF). However, the response to the drug may vary between …
Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril–valsartan: does money matter?
I Cavallari, E Maddaloni… - European Journal of …, 2021 - academic.oup.com
The pandemic of heart failure (HF) represents a major global health problem with about 26
million people affected worldwide. Since HF occurs most commonly in elderly people, with …
million people affected worldwide. Since HF occurs most commonly in elderly people, with …
[HTML][HTML] Los inhibidores SGLT2: una mirada al futuro del tratamiento de la insuficiencia cardiaca
A Nouel, JL Winter, L Sepúlveda - Revista médica de Chile, 2022 - SciELO Chile
Resumen NOUEL, Ana; WINTER, José Luis y SEPULVEDA, Luis. Los inhibidores SGLT2:
una mirada al futuro del tratamiento de la insuficiencia cardiaca. Rev. méd. Chile [online] …
una mirada al futuro del tratamiento de la insuficiencia cardiaca. Rev. méd. Chile [online] …